ESCRS - Descemet’s membrane endothelial keratoplasty ;
ESCRS - Descemet’s membrane endothelial keratoplasty ;

Descemet’s membrane endothelial keratoplasty

Descemet’s membrane endothelial keratoplasty
Boris Malyugin
Boris Malyugin
Published: Friday, February 10, 2017
Boris Malyugin MD, PhD showed delegates at the 21st ESCRS Winter Meeting several videos of very tricky surgical problems he has encountered during Descemet’s membrane endothelial keratoplasty (DMEK) procedures in which the DM transplant became “glued” to the iris. Presenting at the ESCRS/EuCornea Cornea Day in Maastricht, The Netherlands, Dr Malyugin stressed that, although the vast majority of DMEK procedures are uneventful, proper placement of the membrane can encounter several pitfalls. Dr Malyugin, Moscow, Russia, presented videos of two cases. In the first case, the transplant was very strongly adherent to the peripheral anterior surface of the iris, requiring a great deal of manipulation and re-dying of the membrane to maintain visibility of the transplant. Despite this manipulation, endothelial cell count was normal for a transplant at six months after surgery. The second case was complicated by minor iris haemorrhage during surgical iridotomy, which he performs with a bent needle and a Sinskey Hook. The bleeding caused strong adhesion between the iris and DM. “Blood in the anterior chamber acts like a fibrin glue, attaching the DM to the surface of the iris,” said Dr Malyugin. He reminded delegates to be careful with the surgical iridectomy in order to avoid bleeding from the iris, and to completely remove all blood clots before membrane injection. In this case, relieving the adhesion was not possible, and Dr Malyugin realised that the transplant would not survive the manipulation. “As in this case, conversion from DMEK to Descemet's stripping automated endothelial keratoplasty (DSAEK) might sometimes be a good option,” he concluded.
Latest Articles
From Lab to Life: Corneal Repair Goes Cellular

Long-awaited cellular therapies for corneal endothelial disease enter the clinic.

Read more...

Balancing Innovation and Safety

Ensuring access to advanced cell therapies amid regulatory overhaul.

Read more...

With Eyes on Its Future, ESCRS Celebrates Its Past

Winter Meeting offers opportunities to experiment with new concepts and formats.

Read more...

Best of ESCRS Winter Meeting 2024

Read more...

Following the New Generation

EDOF IOLs an option for eyes with mild comorbidities, showing potential in mini-monovision strategies.

Read more...

Refocus on Multifocals

Trifocal IOLs continue to improve as consensus grows regarding indications and contraindications.

Read more...

Common Myths in Presbyopia Correction

Patient education key to satisfaction with refractive IOLs.

Read more...

Reversible Multifocality

Two-lens combination offers low-risk spectacle independence for cataract patients and presbyopes.

Read more...

Managing a Cataract Surgery Refractive Miss

Weighing the pros and cons of options for intraocular intervention.

Read more...

Unleashing OCT’s Full Potential

Performance of newest tool for corneal evaluation meets or beats older standard technologies.

Read more...

;